KEQU
KEQU
NASDAQ · Health Care

Kewaunee Scientific Cp

$38.64
-0.04 (-0.10%)
Financial Highlights (FY 2026)
Revenue
241.57M
Net Income
11.46M
Gross Margin
28.6%
Profit Margin
4.7%
Rev Growth
+12.5%
D/E Ratio
1.02
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 28.6% 28.6% 50.5% 50.5%
Operating Margin 7.4% 6.7% 10.7% 9.9%
Profit Margin 4.7% 4.5% 9.0% 9.5%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 241.57M 214.73M 59.81M 50.24M
Gross Profit 69.16M 61.48M 30.19M 25.36M
Operating Income 17.85M 14.28M 6.40M 4.98M
Net Income 11.46M 9.17M 5.37M 4.75M
Gross Margin 28.6% 28.6% 50.5% 50.5%
Operating Margin 7.4% 6.7% 10.7% 9.9%
Profit Margin 4.7% 4.5% 9.0% 9.5%
Rev Growth +12.5% +12.5% +13.1% -4.7%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 27.91M 27.91M 32.14M 29.26M
Total Equity 27.47M 27.47M 76.20M 84.12M
D/E Ratio 1.02 1.02 0.42 0.35
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 22.86M 19.31M 8.28M 7.47M
Free Cash Flow 3.50M 3.36M